Literature DB >> 3954042

Use of N-acetyl-2'-O-methyllactosamine as a specific acceptor for the determination of alpha-L-(1----3)-fucosyltransferase in human serum.

R Madiyalakan, S Yazawa, S A Abbas, J J Barlow, K L Matta.   

Abstract

A synthetic substrate, N-acetyl-2'-O-methyllactosamine, was employed as a specific acceptor for alpha-L-(1----3)-fucosyltransferase from human serum. The fucosyl linkage of the product from this substrate was characterized by hydrolysis with a specific alpha-L-(1----3)/(1----4)-fucosidase. Using this acceptor, the pH optimum for the serum alpha-L-(1----3)-fucosyltransferase was 6.5. The enzyme was activated by Mn2+ or Mg2+ ions and was inhibited by EDTA. The apparent Km for this enzyme using N-acetyl-2'-O-methyllactosamine was 20.4 mM and Vmax was 5.6 pmol/h/ml serum.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954042     DOI: 10.1016/0003-2697(86)90112-0

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  6 in total

1.  Tumor-related elevation of serum (alpha 1----3)-L-fucosyltransferase activity in gastric cancer.

Authors:  S Yazawa; T Asao; Y Nagamachi; S A Abbas; K L Matta
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

2.  A new method for assaying adhesion of cancer cells to the greater omentum and its application for evaluating anti-adhesion activities of chemically synthesized oligosaccharides.

Authors:  A Okamura; S Yazawa; T Nishimura; S Tanaka; I Takai; S Kudo; T Asao; H Kuwano; K L Matta; S Akamatsu; N Kochibe
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Tumor cells as the origin of elevated serum alpha1,3fucosyltransferase in association with malignancy.

Authors:  T Asao; H Kuwano; J Nakamura; A Okamura; E G Berger; K L Matta; S Yazawa
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

4.  A novel method for determination of alpha1,6fucosyltransferase activity using a reducing oligosaccharide from egg yolk as a specific acceptor.

Authors:  S Yazawa; N Kochibe; T Nishimura; C Shima; I Takai; M Adachi; T Asao; T Hada; Y Enoki; L R Juneja
Journal:  Glycoconj J       Date:  1998-09       Impact factor: 2.916

5.  Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients.

Authors:  Shin Yazawa; Ryo Takahashi; Takehiko Yokobori; Rie Sano; Akira Mogi; Abby R Saniabadi; Hiroyuki Kuwano; Takayuki Asao
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

6.  The presence of CA19-9 in serum and saliva from Lewis blood-group negative cancer patients.

Authors:  S Yazawa; T Asao; H Izawa; Y Miyamoto; K L Matta
Journal:  Jpn J Cancer Res       Date:  1988-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.